Expectations trend
FY2027 · fiscal year ending 2027-12-28 · fmp
SunPower, Inc. (SPWR)
NASDAQInformation TechnologySolarSnapshot 2026-11-04
$0.25+1.40%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySolarSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SPWR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
5 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Annual revenue exceeds $400 million in fiscal year 2026 | A primary condition in SunPower, Inc.'s published investment case. The stated target is >= $400 million. | Broken | Annual revenue falls below $350 million in 2026 | Revenue: $54.858M FY2026-Q2; GAAP. Published target: >= $400 million. Target period is not explicitly aligned with this observation. Aug 21, 202654,858,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-28 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround rather than a durable compounder. The thesis is on watch: management has reduced costs, but operating losses remain substantial and recent financial performance is weak.
SPWR screens as cheap versus peers, but confidence in that comparison is low. The expectations gap is negative, and the evidence describes the current pricing as justified by a turbulent sector, not as a sign that the business is overlooked.
Near term, elevated earnings-miss risk and falling company momentum make execution uncertain. Management has cut costs, with operating expenses declining from Q1 to Q2 2026, but quarterly revenue also fell and the evidence does not establish progress toward the full-year revenue goal or cashflow breakeven.
The multi-year thesis hinges on whether cost cuts can reduce losses while revenue grows and cashflow reaches breakeven. A guidance cut would add pressure; easier rates or steadier results from sector peers could improve the backdrop, while the recently announced acquisition is a potential change whose effect is not yet established.
Over the next 1 to 3 years, SPWR remains a fragile turnaround with some cost-cutting progress but weak results and important management goals still to prove. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in a supplied disclosure. Management reported: “Our 2026 plan is to grow our combined companies to over $400 million in revenue.”” “We expect to grow Q3’26 revenue to $75-plus million and reduce our operating loss by 90% from ($12.5 million) in Q2’26 to less than ($1.0 million) in Q3’26.” Revenue was $54.858 million in 2026-Q2.
Manage capital allocation through debt and equity transactions | A supporting condition in SunPower, Inc.'s published investment case. The stated target is Maintain active capital allocation without worsening financial health. | Under Pressure | Capital moves increase financial risk or dilute shareholders significantly | 103.1M shares issued vs no dilution limit September 2026 private placement issued 103.1M shares, causing significant dilution and financial risk. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Strengthen leadership with new CFO to improve financial strategy | New CFO hire may improve financial management. | Under Pressure | Leadership changes cause disruption or fail to improve results | Qualitative: CFO impact unproven; Q3 loss target <$1M vs cash constraints Northland cut price target on cash constraints; shares fell 17.2% after $26.2M raise; Q3 loss target <$1M. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating losses improve to about -$3 million by Q2 2026 | Operating losses are shrinking, from -$19.2M in Q1 2026 to -$3M in Q2. | Broken | Operating losses worsen beyond -$10 million in 2026-Q2 | Operating income: $-23.456M FY2026-Q2; GAAP. Published target: >= -$3 million (loss). The target does not explicitly identify fiscal versus calendar quarters. Aug 21, 2026-23,456,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “2 of 9 Total Bookings Signed Contract + Design Complete + Funding Approved $13.0 Million in Permanent Cost Reductions The actions to stem Q1’26 losses – a RIF, the implementation of a four-day workweek (to minimize the RIF), and structured cost-cutting – were made in May and reduced our quarterly fixed operating expenses by about $7.1 million.” “In Q3’26, we will further reduce our fixed expenses by another $5.9 million with more cost cutting and “right-sizing” the combined New Homes-Cobalt management teams.” Operating income was $-23.456 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Revenue reaches $96 million by Q3 2026 for cashflow breakeven | SunPower aims to reach cashflow breakeven by Q3 2026 with $96M revenue. | Broken | Revenue falls below $75 million in 2026-Q3 | Revenue: $54.858M FY2026-Q2; GAAP. Published target: >= $96 million. The stored target says 2026-Q3; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 21, 202654,858,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “We expect to grow Q3’26 revenue to $75-plus million and reduce our operating loss by 90% from ($12.5 million) in Q2’26 to less than ($1.0 million) in Q3’26.” “Finally, we forecast our Q3’26 revenue will climb to $96 million – our cashflow breakeven point – as shown on the revenue graph below, which also shows our current operating income breakeven revenue of $76 million.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.52 → $-0.06 · observed estimates
$0.58B → $0.30B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-25 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-26 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-27 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-28 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-29 | $0.52 | $579,000,000 | 2 / 1 |
| 2026-07-30 | $0.28 | $434,000,000 | 2 / 1 |
| 2026-07-31 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-01 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-02 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-03 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-04 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-05 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-06 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-08 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-09 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-10 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-12 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-13 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-14 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-15 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-16 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-17 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-18 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-19 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-08-20 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-21 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-22 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-23 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-24 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-25 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-26 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-27 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-28 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-29 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-30 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-08-31 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-01 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-02 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-03 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-04 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-05 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-06 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-07 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-08 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-09 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-10 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-11 | $0.04 | $340,000,000 | 1 / 1 |
| 2026-09-12 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-13 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-14 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-15 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-16 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-17 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-18 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-19 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-20 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-21 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-22 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-23 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-24 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-25 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-26 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-27 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-28 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-29 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-09-30 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-10-01 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-10-02 | $0.04 | $340,000,000 | 2 / 1 |
| 2026-10-03 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-04 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-05 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-06 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-07 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-08 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-09 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-10 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-11 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-12 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-13 | $0.03 | $325,000,000 | 2 / 1 |
| 2026-10-14 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-15 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-16 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-17 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-18 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-19 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-20 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-21 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-22 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-23 | $0.03 | $325,000,000 | 1 / 1 |
| 2026-10-24 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-25 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-26 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-27 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-28 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-29 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-30 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-10-31 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-11-01 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-11-02 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-11-03 | $-0.06 | $300,000,000 | 1 / 1 |
| 2026-11-04 | $-0.06 | $300,000,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 18, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings5 of 5 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.